Macquarie Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.7M | Sell |
65,294
-24,271
| -27% | -$5.03M | 0.06% | 244 |
|
|
2026
Q1 | $20.1M | Sell |
89,565
-40,777
| -31% | -$10.2M | 0.12% | 152 |
|
|
2025
Q4 | $31.4M | Buy |
130,342
+28,988
| +29% | +$7.41M | 0.14% | 131 |
|
|
2025
Q3 | $27.7M | Buy |
101,354
+22,956
| +29% | +$6.27M | 0.03% | 572 |
|
|
2025
Q2 | $20.2M | Sell |
78,398
-84,666
| -52% | -$20.2M | 0.02% | 663 |
|
|
2025
Q1 | $36.5M | Buy |
163,064
+31,707
| +24% | +$7.4M | 0.05% | 487 |
|
|
2024
Q4 | $14M | Buy |
131,357
+34,650
| +36% | +$8.34M | 0.02% | 741 |
|
|
2024
Q3 | $23.6M | Sell |
96,707
-9,779
| -9% | -$2.19M | 0.03% | 628 |
|
|
2024
Q2 | $20.4M | Buy |
106,486
+14,374
| +16% | +$2.92M | 0.02% | 650 |
|
|
2024
Q1 | $3.7M | Buy |
92,112
+61,872
| +205% | +$11.3M | ﹤0.01% | 1051 |
|
|
2023
Q4 | $5.2M | Sell |
30,240
-34,992
| -54% | -$5.38M | 0.01% | 959 |
|
|
2023
Q3 | $1.96M | Buy |
65,232
+46,401
| +246% | +$8.39M | ﹤0.01% | 1166 |
|
|
2023
Q2 | $4.11M | Buy |
18,831
+8,137
| +76% | +$1.81M | ﹤0.01% | 971 |
|
|
2023
Q1 | $2.22M | Buy |
10,694
+526
| +5% | +$114K | ﹤0.01% | 1130 |
|
|
2022
Q4 | $2.12M | Sell |
10,168
-3,212
| -24% | -$706K | ﹤0.01% | 1189 |
|
|
2022
Q3 | $2.92M | Buy |
13,380
+947
| +8% | +$216K | ﹤0.01% | 1114 |
|
|
2022
Q2 | $2.61M | Buy |
12,433
+7,116
| +134% | +$1.51M | ﹤0.01% | 1205 |
|
|
2022
Q1 | $1.29M | Sell |
5,317
-31,621
| -86% | -$7.65M | ﹤0.01% | 1489 |
|
|
2021
Q4 | $9.62M | Sell |
36,938
-18,435
| -33% | -$4.78M | 0.01% | 941 |
|
|
2021
Q3 | $14.6M | Buy |
55,373
+31,175
| +129% | +$8.52M | 0.01% | 844 |
|
|
2021
Q2 | $5.97M | Sell |
24,198
-8,936
| -27% | -$1.88M | ﹤0.01% | 1082 |
|
|
2021
Q1 | $6.43M | Buy |
33,134
+3,293
| +11% | +$660K | 0.01% | 846 |
|
|
2020
Q4 | $6.34M | Sell |
29,841
-6,253
| -17% | -$1.25M | 0.01% | 825 |
|
|
2020
Q3 | $6.62M | Buy |
36,094
+25,842
| +252% | +$4.77M | 0.01% | 748 |
|
|
2020
Q2 | $1.97M | Sell |
10,252
-20,807
| -67% | -$3.4M | ﹤0.01% | 1014 |
|
|
2020
Q1 | $4.58M | Buy |
31,059
+20,475
| +193% | +$3.26M | 0.01% | 735 |
|
|
2019
Q4 | $1.64M | Sell |
10,584
-20,732
| -66% | -$2.99M | ﹤0.01% | 1096 |
|
|
2019
Q3 | $2.51M | Sell |
31,316
-46,745
| -60% | -$6.12M | ﹤0.01% | 965 |
|
|
2019
Q2 | $9.53M | Buy |
78,061
+29,102
| +59% | +$3.22M | 0.02% | 614 |
|
|
2019
Q1 | $5.09M | Buy |
48,959
+7,598
| +18% | +$784K | 0.01% | 779 |
|
|
2018
Q4 | $4.71M | Sell |
41,361
-53,400
| -56% | -$5.72M | 0.01% | 757 |
|
|
2018
Q3 | $10.9M | Buy |
94,761
+88,361
| +1,381% | +$9.68M | 0.02% | 623 |
|
|
2018
Q2 | $663K | Hold |
6,400
| – | – | ﹤0.01% | 1282 |
|
|
2018
Q1 | $630K | Sell |
6,400
-173,923
| -96% | -$16.4M | ﹤0.01% | 1315 |
|
|
2017
Q4 | $15.3M | Buy |
180,323
+123,279
| +216% | +$10.2M | 0.03% | 533 |
|
|
2017
Q3 | $4.39M | Sell |
57,044
-27,638
| -33% | -$2.11M | 0.01% | 782 |
|
|
2017
Q2 | $6.59M | Sell |
84,682
-45,018
| -35% | -$3.22M | 0.01% | 686 |
|
|
2017
Q1 | $9.34M | Sell |
129,700
-114,088
| -47% | -$7.88M | 0.02% | 624 |
|
|
2016
Q4 | $15.1M | Sell |
243,788
-248,207
| -50% | -$15.2M | 0.03% | 515 |
|
|
2016
Q3 | $31.9M | Buy |
491,995
+13,702
| +3% | +$912K | 0.06% | 280 |
|
|
2016
Q2 | $30.2M | Sell |
478,293
-304,258
| -39% | -$17.9M | 0.06% | 269 |
|
|
2016
Q1 | $45.2M | Buy |
782,551
+595,849
| +319% | +$33.7M | 0.09% | 186 |
|
|
2015
Q4 | $10M | Sell |
186,702
-1,244,715
| -87% | -$70.2M | 0.02% | 542 |
|
|
2015
Q3 | $62.6M | Buy |
1,431,417
+765,878
| +115% | +$41.2M | 0.13% | 131 |
|
|
2015
Q2 | $37.5M | Sell |
665,539
-83,546
| -11% | -$5.27M | 0.07% | 245 |
|
|
2015
Q1 | $53.8M | Sell |
749,085
-754,809
| -50% | -$49M | 0.11% | 188 |
|
|
2014
Q4 | $84.3M | Sell |
1,503,894
-639,720
| -30% | -$33.4M | 0.17% | 109 |
|
|
2014
Q3 | $106M | Buy |
2,143,614
+639,720
| +43% | +$32.6M | 0.23% | 98 |
|
|
2014
Q2 | $76.1M | Buy |
1,503,894
+1,444,332
| +2,425% | +$71.6M | 0.17% | 124 |
|
|
2014
Q1 | $2.66M | Buy |
59,562
+16,250
| +38% | +$730K | ﹤0.01% | 909 |
|
|
2013
Q4 | $2.04M | Buy |
43,312
+20,530
| +90% | +$1.04M | ﹤0.01% | 980 |
|
|
2013
Q3 | $1.2M | Sell |
22,782
-236,838
| -91% | -$11.5M | ﹤0.01% | 1122 |
|
|
2013
Q2 | $11.7M | Buy |
+259,620
| New | +$12.3M | 0.03% | 409 |
|
Other funds holding RMD
Macquarie Group's RMD Position: Q2 2026 in Review
Macquarie Group reduced its ResMed (RMD) stake by 27% in Q2 2026, selling an estimated $5.03M and leaving 65,294 shares worth $12.7M. The position accounts for 0.06% of the portfolio, ranked #244.
Macquarie Group first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $106M in Q3 2014. 885 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Macquarie Group held 65,294 shares of ResMed worth $12.7M as of Q2 2026.
- Macquarie Group sold 24,271 ResMed shares in Q2 2026, an estimated $5.03M.
- ResMed made up 0.06% of Macquarie Group's portfolio in Q2 2026, its #244 holding.
- Macquarie Group first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
- Macquarie Group's ResMed position peaked at $106M in Q3 2014.
- 885 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.